circulating tumor DNA
Showing 1 - 25 of >10,000
Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Measure of the circulating tumor DNA
-
Rouen, FranceCentre Henri Becquerel
Nov 17, 2023
Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas
Not yet recruiting
- Peripheral T Cell Lymphoma
- circulating tumoral DNA detection
-
Rouen, FranceCentre Henri Becquerel
Oct 13, 2023
Renal Cancer Trial in Aarhus N
Enrolling by invitation
- Renal Cancer
-
Aarhus N, DenmarkUrology Department Aarhus University Hospital
Nov 21, 2023
Platinum-resistant Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- pegylated liposomal doxorubicin
- (no location specified)
Aug 2, 2023
NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- Circulating tumor DNA treatment monitoring
-
Naestved, Zealand, Denmark
- +2 more
May 25, 2023
Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized
Recruiting
- Pancreatic Cancer
- No intervention
-
Kashiwa, JapanNational Cancer Center Hospital East
Sep 12, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- ctDNA methylation dynamic monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 14, 2023
Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Pembrolizumab (200mg)
- +2 more
- (no location specified)
Sep 18, 2023
From Patients With High Grade Gliomas
Recruiting
- High Grade Glioma
- Radiotherapy as per standard of care
-
Toronto, Ontario, CanadaUniversity Health Network
Jun 21, 2023
PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (ctDNA analysis)
Recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- ctDNA analysis
-
Verona, ItalyAOUI Verona
May 8, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Postoperative Circulating Tumor DNA Monitoring for Colorectal
Active, not recruiting
- Colorectal Cancer
- Serial ctDNA monitoring
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 28, 2023
Soft Tissue Sarcoma Trial in Toronto (Archival tumor tissue collection and blood draws)
Recruiting
- Soft Tissue Sarcoma
- Archival tumor tissue collection and blood draws
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Circulating Tumor DNA After Stereotactic Ablative Radiotherapy
Recruiting
- Non Small Cell Lung Cancer
-
London, Ontario, CanadaLondon Health Sciences Centre
Jun 19, 2023
Glioma, Circulating Tumor Cell Trial in Sabadell (Liquid Biopsy)
Recruiting
- Glioma
- Circulating Tumor Cell
- Liquid Biopsy
-
Sabadell, Barcelona, SpainHospital Universitari Parc Taulí
Jul 19, 2023
Circulating Tumor DNA Study in Patients With Endometrial Cancer
Recruiting
- Endometrial Cancer
- Whole blood
-
Paris, FranceHôpital Cochin
Jul 12, 2023
Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)
Recruiting
- Locally Advanced Rectal Carcinoma
- Circulating Tumor DNA
- circulating tumor DNA
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Oct 27, 2022
Breast Cancer Undergoing Neoadjuvant Therapy
Recruiting
- Stage I-III Breast Cancer
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 13, 2022
Circulating Tumor DNA to Monitor Efficacy of Total Neoadjuvant
Not yet recruiting
- Colorectal Cancer
- Rectal Cancer
- SignateraTM assay
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 5, 2023
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)
Not yet recruiting
- NSCLC, Stage III
- Signatera ctDNA test
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Mar 13, 2023
Potential Clinical Utilities of Circulating Tumor DNA in
Not yet recruiting
- Gastric Cancer
- Circulating Tumor DNA (ctDNA)
- (no location specified)
Aug 21, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting
- Melanoma
-
Murray, Utah
- +1 more
Feb 17, 2023
Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer
Completed
- Ovarian Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 15, 2022